Innoviva Inc.

Founded in 1996 and headquartered in Burlingame, Innoviva develops and commercializes once‑daily inhaled therapies for COPD and asthma (RELVAR/BREO, ANORO, TRELEGY), plus antibacterials (XERAVA, XACDURO, ZEVTERA) and a single‑dose gonorrhea cure candidate.

Headquarters: United States (USA)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Hospitals and Health Care
Industry: Medical and Diagnostic Laboratories

Employees: 127
HQ: Burlingame

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
INVA	Innoviva Inc. Cap: 1.5B \| P/E: 11.8	EQUITY	NMS	USD	US45781M1018	Active	📈